Nicotine-induced changes of brain β-endorphin

Neuropeptides

Volumn 46, Issue 3, 2012, Pages 125-131

  Gudehithlu, K P ^a,b   Duchemin, A M ^a   Tejwani, G A ^a   Neff, N H ^a   Hadjiconstantinou, M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

Endorphin; Brain; Dopamine D2 like receptors; NAChRs; Nicotine; POMC mRNA

Indexed keywords

BETA ENDORPHIN; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MECAMYLAMINE; MESSENGER RNA; NICOTINE; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CORPUS STRIATUM; DRUG SPECIFICITY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; BETA-ENDORPHIN; BRAIN CHEMISTRY; CORPUS STRIATUM; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MICE; NEURONS; NICOTINE; NICOTINIC AGONISTS; PREFRONTAL CORTEX; PRO-OPIOMELANOCORTIN; RECEPTORS, DOPAMINE D2; RNA, MESSENGER;

EID: 84860673256     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.03.001     Document Type: Article

References (90)

1. Amalric M., Cline E.J., Martinez J.L., Bloom F.E., Koob G.F. Rewarding properties of beta-endorphin as measured by conditioned place reference. Psychopharmacology 1987, 91:14-19.
2. Angulo J.A., McEwens B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 1994, 19:1-28.
3. Armario A. Activation of hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharm. Sci. 2010, 31:318-325.
4. Backon J. Negative correlation of cigarette smoking and dysmenorrhea: reduced prostaglandin synthesis due to beta-endorphin, nicotine or acrolein antagonism. Med. Hypotheses 1989, 28:213-214.
5. Balerio G.N., Aso E., Maldonado R. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Pyschopharmacology 2005, 181:26-269.
6. Balfour, D.J.K., 2009. The neuronal pathways mediating the behavioral and addictive properties of nicotine. In: Henningfield, J.E., et al. (Eds.), Nicotine Psychopharmacology. Handbook of Experimental Pharmacology, vol. 192. pp. 209-233.
7. Bals-Kubik R., Shippenberg T.S., Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. Eur. J. Pharmacol. 1990, 175:63-69.
8. Berrendero F., Kieffer B.L., Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J. Neurosci. 2002, 22:10935-10940.
9. Berrendero F., Mendizabal V., Robledo P., Galeote L., Bilkei-Gorzo A., Zimmer A., Maldonado R. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 2005, 25:1103-1112.
10. Berrendero F., Robledo P., Trigo J.M., Martίn-Garcίa E., Maldonado R. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci. Biobehav. Rev. 2010, 35:220-231.
11. Biala G., Budzynska B., Kruk M. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol. Rep. 2005, 57:755-760.
12. Bloom F., Battenberg E., Rossiers J., Ling N., Guillemin R. Neurons containing β-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. USA 1978, 75:1591-1595.
13. Boyadjieva N.I., Sarkar D.K. The secretory response of hypothalamic β-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal. Life Sci. 1997, 61:59-66.
14. Bronstein D.M., Schafer M.K., Watson S.J., Akil H. Evidence that β-endorphin is synthesized in cells in nucleus tractus solitarius: detection of POMC mRNA. Brain Res. 1992, 787:269-275.
15. Civelli O., Birnberg N., Herbert E. Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species. J. Biol. Chem. 1982, 257:6783-6787.
16. Conte-Devolx B., Oliver C., Giraud P., Gillioz P., Castanas E., Lissitzsky J.C., Boudouresque F., Millet Y. Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life Sci. 1981, 28:1067-1073.
17. Davenport K.E., Houdi A.A., Van Loon G.R. Nicotine protects against mu-opioid receptor antagonism by β-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci. Lett. 1990, 113:40-46.
18. del Arbol J.L., Raya Muñoz J., Ojeda L., Lόpez Cascales A., Rico Irles J., Miranda M.T., Ruiz Requena M.E., Aguirre J.C. Plasma concentrations of beta-endorphin in smokers who consume different numbers of cigarettes per day. Pharmacol. Biochem. Behav. 2000, 67:25-28.
19. Dhatt R.K., Gudehithlu K.P., Wemlinger T.A., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J. Neurochem. 1995, 64:1873-1878.
20. Doron R., Fridman L., Yadid G. Dopamine-D2 receptors in the acute nucleus modulate cocaine seeking behavior. NeuroReport 2006, 17:1633-1636.
21. Drews E., Zimmer A. Modulation of alcohol and nicotine responses through the endogenous opioid system. Progress Neurobiol. 2010, 90:1-15.
22. Finley J.C., Lindstrom P., Petrusz P. Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 1981, 33:28-42.
23. Frazier C.J., Buhler A.V., Weiner J.L., Dunwiddie T.V. Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampall interneurons. J. Neurosci. 1998, 18:8228-8235.
24. Galeote L., Berrendero F., Bura S.A., Zimmer A., Maldonado R. Prodynorphin gene disruption increases the sensitivity of nicotine self-administration in mice. Int. J. Neuropsychopharmacol. 2009, 12:615-625.
25. Gee C.E., Chen C.-L., Roberts J.L., Thompson R., Watson S.J. Identification of proopiomelanocortin neurons in rat hypothalamus by in situ cDNA-mRNA hybridization. Nature 1983, 306:374-376.
26. Gilbert D.G., Meliska C.J., Williams C.L., Jensen R.A. Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology 1992, 106:275-281.
27. Goktalay G., Cavun S., Levendusky M.C., Hamilton J.R., Millington W.R. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur. J. Pharmacol. 2006, 530:95-102.
28. Grauerholz B.L., Jacobson J.D., Handler M.S., Millington W.R. Detection of pro-opiomelanocortin mRNA in human and rat caudal medulla by RT-PCR. Peptides 1998, 19:939-948.
29. Hadjiconstantinou M., Neff N.H. Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 2011, 60:1209-1220.
30. Hagino Y., Okuwa M., Moroji T. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to the effects of ceruletide in chronically haloperidol-treated rats. Neuropeptides 1991, 18:1-14.
31. 125I]α-bungarotoxin binding sites in the brain of Macaca mulatta. J. Comp. Neurol. 2003, 461:49-60.
32. Han Z.-Y., Le Novére N., Zoli M., Hill J.A., Champtiaux N., Changeux J.-P. Localization of nAChR subunit mRNA in the brain of Macaca mulatta. Eur. J. Neurosci. 2000, 12:3664-3674.
33. Hegadoren K.M., O'Donnell T., Lanius R., Coupland N.J., Lacaze-Masmonteil N. The role of β-endorphin in the pathophysiology of major depression. Neuropeptides 2009, 43:341-353.
34. Hill J.A., Zoli M., Bourgeois J.-P., Changeux J.-P. Immunohistochemical localization of a neuronal nicotinic receptor: the β2-subunit. J. Neurosci. 1993, 13:1551-1568.
35. Höllt V., Horn G. Effect of nicotine on mRNA levels encoding opioid peptides, vasopressin, and α3 nicotinic receptor subunit in the rat. Clin. Investig. 1992, 70:224-231.
36. Höllt V., Bergmann M. Effects of acute and chronic haloperidol on the concentrations of immunoreactive beta-endorphin in plasma, pituitary and brain of rats. Neuropharmacology 1982, 21:147-154.
37. Horvath T.L., Naftolin F., Leranth C. Beta-endorphin innervation of dopamine neurons in the rat hypothalamus: a light and electron microscopic double immunostaining study. Endocrinology 1992, 131:1547-1555.
38. Houdi A.A., Pierzchala K., Marson L., Palkovits M., Van Loon G.R. Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides 1991, 12:161-166.
39. Houdi A.A., Dasgupta R., Kindy M.S. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res. 1998, 799:257-263.
40. Ise Y., Narita M., Nagase H., Suzuki T. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology 2000, 151:49-54.
41. Ishii K., Wong J.K., Sumikawa K. Comparison of α2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice. J. Comp. Neurol. 2005, 493:241-260.
42. Isola R., Duchemin A.M., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Glutamate receptors participate in the nicotine induced changes of met-enkephalin in striatum. Brain Res. 2000, 878:72-78.
43. Isola R., Zhang H., Duchemin A.M., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse. Neurosci. Lett. 2002, 325:67-71.
44. Isola R., Zhang H., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal. Synapse 2008, 62:448-455.
45. Isola R., Zhang H., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum. Psychopharmacology 2009, 201:507-516.
46. Jensen R.A., Gilbert D.G., Meliska C.J., Landrum T.A., Szary A.B. Characterization of a dose-response curve for nicotine-induced conditional taste aversion in rats: relationship to elevation of plasma beta-endorphin concentration. Behav. Neural. Biol. 1990, 53:428-440.
47. Khan Z.U., Gutierrez A., Martin R., Penafiel A., Rivera A., De La Calle A. Differential regional and cellular distribution of dopamine D2-like receptors: an immunohistological study of sub-type specific antibodies in rat and human brain. J. Comp. Neurol. 1998, 402:353-371.
48. Le Merrer J., Becker J.A.J., Befort K., Kieffer B.L. Reward processing by the opioid system in the brain. Physiol. Rev. 2009, 89:379-1412.
49. Leriche M., Cote-Velez A., Méndez M. Presence of pro-opiomelanocortin mRNA in the rat medial prefrontal cortex, nucleus accumbens and ventral tegmental area: studies by RT-PCR and in situ hybridization techniques. Neuropeptides 2007, 41:421-431.
50. Livingstone P.D., Srinivasan J., Kew J.N., Dawson L.A., Gotti C., Moretti M., Shoaib M., Wonnacott S. Alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur. J. Neurosci. 2009, 29:539-550.
51. Locatelli V., Petraglia F., Penalva A., Panerai A.E. Effects of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat. Life Sci. 1983, 33:1711-1717.
52. Lutfy K., Brown M.C., Nerio N., Aimiuwu O., Tran B., Anghel A., Friedman T.C. Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J. Neurochem. 2006, 99:1321-1327.
53. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., Wilson O.B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 1993, 112:339-342.
54. Marshall D.L., Redfern P.H., Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naïve and chronic treated rats. J. Neurochem. 1997, 68:1511-1519.
55. Marty M.A., Erwin V.G., Cornell K., Zgombick J.M. Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands in vitro. Pharmacol. Biochem. Behav. 1985, 22:317-325.
56. Meeker R.B., Michels K.M., Libber M.T., Hayward J.N. Characteristics and distribution of high-and low-affinity alpha bungarotoxin sites in the rat hypothalamus. J. Neurosci. 1986, 6:1866-1875.
57. Mello K.N. Hormones, nicotine and cocaine: clinical studies. Horm. Behav. 2010, 58:57-71.
58. Olive M.F., Koening H.N., Nannini M.A., Hodge C.W. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J. Neurosci. 2001, 21:RC184.
59. Papke R.L., Sanberg P.R., Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 2001, 297:646-656.
60. Pierzchala K., Houdi A.A., Van Loon G.R. Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin. Peptides 1987, 8:1035-1043.
61. Perry D.C., Xiao Y., Nguyen H.N., Musachio J.L., Dávila-Garcia M., Keller K.J. Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography. J. Neurochem. 2002, 82:468-481.
62. Pomerleau O.F. Endogenous opioids and smoking: a review of progress and problems. Psychoneuroendocrinology 1998, 23:115-1130.
63. Pomerleau O.F., Fertig J.B., Seyler L.E., Jaffe J. Neuroendocrine reactivity in nicotine smokers. Psychopharmacology 1983, 81:245-259.
64. Rasmussen D.D. Effects of chronic nicotine treatment and withdrawal on hypothalamic proopiomelanocortin gene expression and neuroendocrine regulation. Psychoneuroendocrinology 1998, 23:245-259.
65. Rasmussen D.D., Liu J.H., Wolf P.L., Yen S.S. Neurosecretion of human hypothalamic immunoreactive beta-endorphin: in vitro regulation by dopamine. Neuroendocrinology 1987, 45:197-200.
66. Rattan A.K., TeJwani G.A. Effect of chronic treatment with morphine, midazolam, and both together on beta-endorphin levels in the rat. Brain Res. Bull. 1996, 41:335-341.
67. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Bell G.I., Reisine T. Pharmacological characterization of the cloned kappa-, delta- and mu-opioid receptors. Mol. Pharmacol. 1994, 45:330-334.
68. Rosecrans J.A., Hendry J.S., Hong J.S. Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse. Pharmacol. Biochem. Behav. 1985, 23:141-143.
69. Roth-Deri I., Green-Sadan T., Yadid G. β-Endorphin and drug-induced reward and reinforcement. Prog. Neurobiol. 2008, 86:1-21.
70. Roth-Deri I., Zangen A., Aleli M., Goelman R.G., Pelled G., Nakash R., Gispan-Herman I., Green T., Shaham Y., Yadid G. Effect of experimenter-delivered and self-administered cocaine on extracellular β-edorphin levels in nucleus accumbens. J. Neurochem. 2003, 84:930-938.
71. Séguéla P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 1993, 13:596-604.
72. Seyler L.E., Pomerleau O.F., Fertig J.B., Hunt D., Parker K. Pituitary hormone response to cigarette smoking. Pharmacol. Biochem. Behav. 1986, 24:159-162.
73. Shioda S., Nakajo S., Hirabayashi T., Nakayama H., Nakaya K., Matsuda K., Nakai Y. Neuronal nicotinic acetylcholine receptor in the hypothalamus: morphological diversity and neuroendocrine regulations. Mol. Brain Res. 1997, 47:45-54.
74. Spanagel R., Herz A., Bals-Kubic R., Shippenberg T.S. Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology 1991, 104:51-56.
75. Spanagel R., Herz A., Shippenberg T.S. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 1990, 190:177-184.
76. Stengaard-Pedersen K., Larsson L.I. Comparative immunocytochemical localization of putative opioid ligands in the central nervous system. Histochemistry 1981, 73:89-114.
77. Sweep C.G., Boersma C.J., Wiegant V.M. Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain. Neuropharmacology 1990, 29:61-68.
78. Tejwani G.A., Vaswani K.K., Barbacci J.C., Richard C.W., Bianchine J.R. Effect of oral contraceptives on rat brain and pituitary beta-endorphin. Life Sci. 1983, 33:519-522.
79. Trigo J.M., Martin-Garcia E., Berrendero F., Robledo P., Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 2010, 108:183-194.
80. Trigo J.M., Zimmer A., Maldonado R. Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin. Neuropharmacology 2009, 56:1147-1153.
81. Vaswani K.K., Richard C.W., Tejwani G.A. A cold swim stress-induced changes in the levels of opioid peptides in the rat CNS and peripheral tissues. Pharmacol. Biochem. Behav. 1988, 29:163-168.
82. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of apha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study the rat. J. Comp. Neurol. 1989, 284:314-335.
83. Watkins S.S., Stinus L., Koob G.F., Markou A. Reward and somatic changes during precipitated withdrawal in rats: centrally and peripherally mediated effects. J. Pharmacol. Exp. Ther. 2000, 292:1053-1064.
84. 3H]-methyllycaconitine in the mouse brain. Eur. J. Neurosci. 1999, 11:2689-2696.
85. Winzer-Serhan U.H., Leslie F.M. Co-distribution of nicotinic acetylcholine receptor subunit α3 and β4 mRNAs during rat brain development. J. Comp. Neurol. 1997, 386:540-554.
86. Wonnacott S., Barik J., Dickinson J., Jones I.W. Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. J. Mol. Neurosci. 2006, 30:137-140.
87. Xue Y., Domino E.F. Tobacco/nicotine and endogenous brain opioids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1131-1138.
88. Zakarian S., Smyth D.G. Distribution of β-endorphin-related peptides in rat pituitary and brain. Biochem. J. 1982, 202:561-571.
89. Zarrindast M.R., Pazouki M., Nassiri-Rad S. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol. Toxicol. 1997, 81:209-213.
90. Zarrindast M.R., Faraji N., Rostami P., Sahraei H., Ghoshoumi H. Cross-tolerance between morphine-and nicotine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 2003, 74:363-369.